Tissue Analysis Services, Pharma Regulatory Support, Clinical Diagnostics, Diagnostic Biomarker, Drug Development, Scientists, Immuno-Oncology Drug Development, Biomarker Strategy, Companion Diagnostics, CDx, Image Analysis Technology, Global Regulatory Strategy, Accelerate Trials, Companion Diagnostic Biomarker Events Archive - Flagship Biosciences

2023 Upcoming Events

Oncology Companion Diagnostics Xchange West Coast | San Francisco, CA | February 6-9, 2023
Gene Therapy for Muscular Disorders Summit | Boston, MA | February 21-23, 2023

Gene Therapy for Muscular Disorders

Reuniting 100+ leading experts in biotech, pharma, and academia February 21-23, 2023 We’re headed to Boston to join other leading experts in biotech, pharma and

Oncology Companion Diagnostics Xchange West Coast

Join Flagship for the Oncology Companion Diagnostics Xchange at hubXchange West February 6-9, 2023 Attending hubXchange West? Meet with us to discuss how we can

Spatial Biology for Immuno-Oncology Summit 2023

Spatial Biology for Immuno-Oncology Summit 2023

Visit Flagship at the SB-IO Summit January 17-19, 2023 Attending the inaugural SB-IO Summit? Stop by our booth to discuss how we can partner with

ASH 2022

Visit Flagship at ASH | Booth #1015 December 10-13, 2022 Attending ASH 2022? Stop by our booth to discuss how we can partner with you

SITC 2022

Visit Flagship at SITC | Booth #818 November 8-12, 2022 Stop by our booth to meet our new CSO Tom Turi, Ph.D., and talk with

World CB & CDx 2022

Visit Flagship at World CB & CDx | Booth #4 Boston, MA | September 26-29, 2022 Stop by our booth to talk with us about

READY TO TAKE THE NEXT STEP?

Our Services

Pharma

Cell-based image analysis, assays, and partnership to advance clinical trials and regulatory acceptance.

Clinical Diagnostics

Dependable clinical diagnostic testing to connect patients to individualized, immuno-oncology therapies.

Flagship carefully tracks our tissue to ensure we can analyze every assay and stay on schedule.

We are trying to bridge from the discovery stage to clinical development. Flagship's pathologists and scientists provide critical input and the company helps us organize and analyze an incredible amount of data. I highly recommend Flagship for its expertise and support for drug development projects.

During clinical trials, I interact with our manufacturing, legal, pre-clinical, and biomarker teams. Our Flagship project manager understands our tight timeline and ensures delivery of the data we need, when we need it.

We are pleased to partner with Flagship Biosciences to integrate their machine learning/AI tools to provide cancer marker detection.

Flagship’s image analysis experts are flexible and willing to work with us to develop projects that meet the changing needs of our clinical trials drug development.

Flagship has a high reputation as a supplier of advanced IHC services and their CAP-CLIA environment is a perfect complement to our own testing facilities.

The ease of leveraging Flagship’s powerful solution is yet another massive differentiator of the company. Clients need not have to change their existing workflows, investments in technology, or even the assays that they use.